Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea.

Ji Yun Lee,Ji Hyun Kwon,Joon Young Hur,Jun Ho Yi,Ji Hyun Lee,Hyungwoo Cho,Young Rok Do,Jae-Cheol Jo,Hye Jin Kang,Yougil Koh,Won Sik Lee,Sung Nam Lim,Sang Eun Yoon,Seok Jin Kim,Jeong-Ok Lee

Cancer research and treatment（2023）

引用 0|浏览10

暂无评分

摘要

In conclusion, while pembrolizumab had a modest effect on patients with R/R NKTL, it may be a useful salvage therapy for patients with localized disease and good performance status.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要